Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harbin Hanbang Medical Science and Technology is a Chinese medical device company specializing in the research, development, and manufacturing of vascular therapy systems. The company is primarily known for its External Counterpulsation (ECP) systems and Air Pressure Therapy devices used in the treatment of cardiovascular and cerebrovascular diseases. Their products are designed to improve blood circulation and are widely utilized in hospitals and rehabilitation centers across China and international markets. Hanbang Medical maintains a focus on non-invasive therapeutic solutions for chronic vascular conditions and post-operative recovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harbin Hanbang Medical Science and Technology.